Cargando…

Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease

BACKGROUND: Preclinical Alzheimer’s disease (AD) research strongly depends on transgenic mouse models that display major symptoms of the disease. Although several AD mouse models have been developed representing relevant pathologies, only a fraction of available mouse models, like the Tg4-42 mouse m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinteregger, Barbara, Loeffler, Tina, Flunkert, Stefanie, Neddens, Joerg, Bayer, Thomas A., Madl, Tobias, Hutter-Paier, Birgit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150512/
https://www.ncbi.nlm.nih.gov/pubmed/33646155
http://dx.doi.org/10.3233/JAD-201204
_version_ 1783698169631080448
author Hinteregger, Barbara
Loeffler, Tina
Flunkert, Stefanie
Neddens, Joerg
Bayer, Thomas A.
Madl, Tobias
Hutter-Paier, Birgit
author_facet Hinteregger, Barbara
Loeffler, Tina
Flunkert, Stefanie
Neddens, Joerg
Bayer, Thomas A.
Madl, Tobias
Hutter-Paier, Birgit
author_sort Hinteregger, Barbara
collection PubMed
description BACKGROUND: Preclinical Alzheimer’s disease (AD) research strongly depends on transgenic mouse models that display major symptoms of the disease. Although several AD mouse models have been developed representing relevant pathologies, only a fraction of available mouse models, like the Tg4-42 mouse model, display hippocampal atrophy caused by the death of neurons as the key feature of AD. The Tg4-42 mouse model is therefore very valuable for use in preclinical research. Furthermore, metabolic biomarkers which have the potential to detect biochemical changes, are crucial to gain deeper insights into the pathways, the underlying pathological mechanisms and disease progression. OBJECTIVE: We thus performed an in-depth characterization of Tg4-42 mice by using an integrated approach to analyze alterations of complex biological networks in this AD in vivo model. METHODS: Therefore, untargeted NMR-based metabolomic phenotyping was combined with behavioral tests and immunohistological and biochemical analyses. RESULTS: Our in vivo experiments demonstrate a loss of body weight increase in homozygous Tg4-42 mice over time as well as severe impaired learning behavior and memory deficits in the Morris water maze behavioral test. Furthermore, we found significantly altered metabolites in two different brain regions and metabolic changes of the glutamate/4-aminobutyrate-glutamine axis. Based on these results, downstream effects were analyzed showing increased Aβ(42) levels, increased neuroinflammation as indicated by increased astro- and microgliosis as well as neuronal degeneration and neuronal loss in homozygous Tg4-42 mice. CONCLUSION: Our study provides a comprehensive characterization of the Tg4-42 mouse model which could lead to a deeper understanding of pathological features of AD. Additionally this study reveals changes in metabolic biomarker which set the base for future preclinical studies or drug development.
format Online
Article
Text
id pubmed-8150512
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-81505122021-06-09 Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease Hinteregger, Barbara Loeffler, Tina Flunkert, Stefanie Neddens, Joerg Bayer, Thomas A. Madl, Tobias Hutter-Paier, Birgit J Alzheimers Dis Research Article BACKGROUND: Preclinical Alzheimer’s disease (AD) research strongly depends on transgenic mouse models that display major symptoms of the disease. Although several AD mouse models have been developed representing relevant pathologies, only a fraction of available mouse models, like the Tg4-42 mouse model, display hippocampal atrophy caused by the death of neurons as the key feature of AD. The Tg4-42 mouse model is therefore very valuable for use in preclinical research. Furthermore, metabolic biomarkers which have the potential to detect biochemical changes, are crucial to gain deeper insights into the pathways, the underlying pathological mechanisms and disease progression. OBJECTIVE: We thus performed an in-depth characterization of Tg4-42 mice by using an integrated approach to analyze alterations of complex biological networks in this AD in vivo model. METHODS: Therefore, untargeted NMR-based metabolomic phenotyping was combined with behavioral tests and immunohistological and biochemical analyses. RESULTS: Our in vivo experiments demonstrate a loss of body weight increase in homozygous Tg4-42 mice over time as well as severe impaired learning behavior and memory deficits in the Morris water maze behavioral test. Furthermore, we found significantly altered metabolites in two different brain regions and metabolic changes of the glutamate/4-aminobutyrate-glutamine axis. Based on these results, downstream effects were analyzed showing increased Aβ(42) levels, increased neuroinflammation as indicated by increased astro- and microgliosis as well as neuronal degeneration and neuronal loss in homozygous Tg4-42 mice. CONCLUSION: Our study provides a comprehensive characterization of the Tg4-42 mouse model which could lead to a deeper understanding of pathological features of AD. Additionally this study reveals changes in metabolic biomarker which set the base for future preclinical studies or drug development. IOS Press 2021-04-06 /pmc/articles/PMC8150512/ /pubmed/33646155 http://dx.doi.org/10.3233/JAD-201204 Text en © 2021 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hinteregger, Barbara
Loeffler, Tina
Flunkert, Stefanie
Neddens, Joerg
Bayer, Thomas A.
Madl, Tobias
Hutter-Paier, Birgit
Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease
title Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease
title_full Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease
title_fullStr Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease
title_full_unstemmed Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease
title_short Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease
title_sort metabolic, phenotypic, and neuropathological characterization of the tg4-42 mouse model for alzheimer’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150512/
https://www.ncbi.nlm.nih.gov/pubmed/33646155
http://dx.doi.org/10.3233/JAD-201204
work_keys_str_mv AT hintereggerbarbara metabolicphenotypicandneuropathologicalcharacterizationofthetg442mousemodelforalzheimersdisease
AT loefflertina metabolicphenotypicandneuropathologicalcharacterizationofthetg442mousemodelforalzheimersdisease
AT flunkertstefanie metabolicphenotypicandneuropathologicalcharacterizationofthetg442mousemodelforalzheimersdisease
AT neddensjoerg metabolicphenotypicandneuropathologicalcharacterizationofthetg442mousemodelforalzheimersdisease
AT bayerthomasa metabolicphenotypicandneuropathologicalcharacterizationofthetg442mousemodelforalzheimersdisease
AT madltobias metabolicphenotypicandneuropathologicalcharacterizationofthetg442mousemodelforalzheimersdisease
AT hutterpaierbirgit metabolicphenotypicandneuropathologicalcharacterizationofthetg442mousemodelforalzheimersdisease